Encompass Health Rehabilitation Institute of Libertyville Opens

A 60-bed inpatient rehabilitation hospital

Encompass Health (NYSE: EHC) announces the opening of Encompass Health Rehabilitation Institute of Libertyville, a 60-bed inpatient rehabilitation hospital located at 1201 American Way.

The hospital serves patients recovering from debilitating illnesses and injuries including strokes and other neurological disorders, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions.

In addition to 24-hour nursing care, Encompass Health Rehabilitation Institute of Libertyville offers physical, occupational and speech therapies to restore functional ability and quality of life. Care is provided by highly specialized nurses, therapists and physicians. The hospital features all private patient rooms, a large therapy gym with advanced rehabilitation technologies and an activities of daily living suite, a therapy courtyard, a cafeteria and a dayroom.

“We are excited to open this new hospital in Libertyville to help restore function, strength, hope and confidence to individuals recovering from major illnesses and injuries with the ultimate goal of helping them return to the community at their highest levels of independence,” said Jennifer Weiss, CEO of Encompass Health Rehabilitation Institute of Libertyville. “This state-of-the-art hospital combined with our team of experts and advanced technologies will allow Northern Illinois residents to receive superior, specialized care close to home.”

Encompass Health Rehabilitation Institute of Libertyville is Encompass Health’s 147th inpatient rehabilitation hospital and its third inpatient rehabilitation hospital in Illinois, with another hospital expected to open in Illinois this year.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version